These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 16920618)

  • 41. Mechanics in human fibroblasts and progeria: Lamin A mutation E145K results in stiffening of nuclei.
    Apte K; Stick R; Radmacher M
    J Mol Recognit; 2017 Feb; 30(2):. PubMed ID: 27677907
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Are there Different Kinds of Aging?
    Diaconeasa AG; Rachita M
    Curr Aging Sci; 2018; 11(1):55-62. PubMed ID: 29149836
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lamin A-linked progerias: is farnesylation the be all and end all?
    Smallwood DT; Shackleton S
    Biochem Soc Trans; 2010 Feb; 38(Pt 1):281-6. PubMed ID: 20074075
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Progeria syndromes and ageing: what is the connection?
    Burtner CR; Kennedy BK
    Nat Rev Mol Cell Biol; 2010 Aug; 11(8):567-78. PubMed ID: 20651707
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nucleolar expansion and elevated protein translation in premature aging.
    Buchwalter A; Hetzer MW
    Nat Commun; 2017 Aug; 8(1):328. PubMed ID: 28855503
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition.
    Glynn MW; Glover TW
    Hum Mol Genet; 2005 Oct; 14(20):2959-69. PubMed ID: 16126733
    [TBL] [Abstract][Full Text] [Related]  

  • 47. p.S143F mutation in lamin A/C: a new phenotype combining myopathy and progeria.
    Kirschner J; Brune T; Wehnert M; Denecke J; Wasner C; Feuer A; Marquardt T; Ketelsen UP; Wieacker P; Bönnemann CG; Korinthenberg R
    Ann Neurol; 2005 Jan; 57(1):148-51. PubMed ID: 15622532
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug treatment.
    Columbaro M; Capanni C; Mattioli E; Novelli G; Parnaik VK; Squarzoni S; Maraldi NM; Lattanzi G
    Cell Mol Life Sci; 2005 Nov; 62(22):2669-78. PubMed ID: 16261260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced SRSF5 Protein Expression Reinforces Lamin A mRNA Production in HeLa Cells and Fibroblasts of Progeria Patients.
    Vautrot V; Aigueperse C; Oillo-Blanloeil F; Hupont S; Stevenin J; Branlant C; Behm-Ansmant I
    Hum Mutat; 2016 Mar; 37(3):280-91. PubMed ID: 26670336
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hutchinson-Gilford progeria syndrome: report of 2 cases and a novel LMNA mutation of HGPS in China.
    Zhang H; Chen X; Guo Y; Liang J; Tang L; Yu H; Yao Z
    J Am Acad Dermatol; 2013 Oct; 69(4):e175-6. PubMed ID: 24034385
    [No Abstract]   [Full Text] [Related]  

  • 51. Homozygous missense mutation in the lamin A/C gene causes autosomal recessive Hutchinson-Gilford progeria syndrome.
    Plasilova M; Chattopadhyay C; Pal P; Schaub NA; Buechner SA; Mueller H; Miny P; Ghosh A; Heinimann K
    J Med Genet; 2004 Aug; 41(8):609-14. PubMed ID: 15286156
    [No Abstract]   [Full Text] [Related]  

  • 52. Cause of progeria's premature aging found: expected to provide insight into normal aging process.
    Vastag B
    JAMA; 2003 May; 289(19):2481-2. PubMed ID: 12759307
    [No Abstract]   [Full Text] [Related]  

  • 53. Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome.
    Capell BC; Erdos MR; Madigan JP; Fiordalisi JJ; Varga R; Conneely KN; Gordon LB; Der CJ; Cox AD; Collins FS
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12879-84. PubMed ID: 16129833
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Skin Disease in Laminopathy-Associated Premature Aging.
    McKenna T; Sola Carvajal A; Eriksson M
    J Invest Dermatol; 2015 Nov; 135(11):2577-2583. PubMed ID: 26290387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Paternal origin of LMNA mutations in Hutchinson-Gilford progeria.
    D'Apice MR; Tenconi R; Mammi I; van den Ende J; Novelli G
    Clin Genet; 2004 Jan; 65(1):52-4. PubMed ID: 15032975
    [No Abstract]   [Full Text] [Related]  

  • 56. Targeted transgenic expression of the mutation causing Hutchinson-Gilford progeria syndrome leads to proliferative and degenerative epidermal disease.
    Sagelius H; Rosengardten Y; Hanif M; Erdos MR; Rozell B; Collins FS; Eriksson M
    J Cell Sci; 2008 Apr; 121(Pt 7):969-78. PubMed ID: 18334552
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dermal fibroblasts in Hutchinson-Gilford progeria syndrome with the lamin A G608G mutation have dysmorphic nuclei and are hypersensitive to heat stress.
    Paradisi M; McClintock D; Boguslavsky RL; Pedicelli C; Worman HJ; Djabali K
    BMC Cell Biol; 2005 Jun; 6():27. PubMed ID: 15982412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New approaches to progeria.
    Kieran MW; Gordon L; Kleinman M
    Pediatrics; 2007 Oct; 120(4):834-41. PubMed ID: 17908771
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bilateral stenosis of carotid siphon in Hutchinson-Gilford progeria syndrome.
    Narazaki R; Makimura M; Sanefuji M; Fukamachi S; Akiyoshi H; So H; Yamamura K; Doisaki S; Kojima S; Ihara K; Hara T; Ohga S
    Brain Dev; 2013 Aug; 35(7):690-3. PubMed ID: 23141186
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hutchinson-Gilford Progeria paves the way for novel targeted anti-aging therapies.
    Dreesen O; Kennedy B
    Med; 2021 Apr; 2(4):353-354. PubMed ID: 35590156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.